Owner Scorecard


← All companies ← ODVWZ Manual OIO → ← OCUL Pharmaceuticals OGN →

OGI, Organigram Global Inc.

Pharmaceuticals consumer brand Unprofitable

A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.

Latest annual: FY2024 40-F · figures as filed, in CAD · US listing is the ordinary share
OGI · Organigram Global Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2024
C$160M
+9.6% YoY · 67% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue C$160M 5-yr avg C$110M
Gross margin 30% 5-yr avg −1%
Operating margin −22.3% 5-yr avg −65.7%
ROIC −9% 5-yr avg −15%
Owner-earnings margin −1% 5-yr avg −33%
Free cash flow margin −1% 5-yr avg −86%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand.
What moves the needle
Operating margin has reached 293% at its best but run negative through the cycle (median −30%) on a 18% gross margin — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Inventory runs near 46% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −9%, above 15% in 1 of 5 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2018–2024

realized figures from each filing · older years to the left
2018’182019’192020’202021’212022’222024’24TTMTTMSep 2024
Income statement
C$12MC$80MC$87MC$79MC$146MC$160MC$160MRevenueRevenue
−21%−31%18%30%30%Gross marginGross mgn
C$36MC$5M(C$146M)(C$92M)(C$43M)(C$36M)(C$36M)Operating incomeOp. inc.
293.0%6.8%−167.6%−116.0%−29.6%−22.3%−22.3%Operating marginOp. mgn
C$21M(C$10M)(C$136M)(C$131M)(C$14M)(C$45M)(C$45M)Net incomeNet inc.
Cash flow & returns
(C$13M)(C$35M)(C$45M)(C$29M)(C$36M)C$4MC$4MOperating cash flowOp. cash
C$509KC$664KC$2MC$2MC$5MC$4MC$4MDepreciationDeprec.
(C$34M)(C$26M)C$90MC$100M(C$27M)C$45MC$45MWorking capital & otherWC & other
C$56MC$109MC$77MC$12MC$49MC$5MC$5MCapexCapex
454.1%135.3%89.0%14.9%33.4%3.0%3.0%Capex / revenueCapex/rev
(C$13M)(C$36M)(C$47M)(C$31M)(C$42M)(C$859K)(C$859K)Owner earningsOwner earn.
−106.3%−44.5%−53.7%−39.2%−28.5%−0.5%−0.5%Owner earnings marginOE mgn
(C$69M)(C$144M)(C$122M)(C$40M)(C$85M)(C$859K)(C$859K)Free cash flowFCF
−556.3%−178.9%−141.0%−51.0%−58.3%−0.5%−0.5%Free cash flow marginFCF mgn
15%-29%-15%-7%-9%-9%ROICROIC
11%-3%-45%-27%-3%-15%-15%Return on equityROE
11%−3%−45%−27%−3%−15%−15%Retained to equityRetained/eq
Balance sheet
C$4MC$17MC$15MC$21MC$46MC$37MC$37MReceivablesReceiv.
C$45MC$93MC$66MC$37MC$50MC$67MC$67MInventoryInvent.
C$11MC$40MC$17MC$19MC$41MC$47MC$47MAccounts payablePayables
C$38MC$69MC$64MC$39MC$56MC$57MC$57MOperating working capitalOper. WC
C$203MC$196MC$170MC$261MC$222MC$262MC$262MCurrent assetsCur. assets
C$11MC$44MC$29MC$26MC$55MC$53MC$53MCurrent liabilitiesCur. liab.
18.1×4.5×5.9×9.9×4.0×4.9×4.9×Current ratioCurr. ratio
C$303MC$429MC$435MC$554MC$577MC$408MC$408MTotal assetsAssets
C$3MC$46MC$104MC$230KC$155KC$25KC$25KTotal debtDebt
C$3MC$46MC$104MC$230KC$155KC$25KC$25KNet debt / (cash)Net debt
3.6×0.6×-24.2×-31.0×-100.6×-83.1×Interest coverageInt. cov.
C$185MC$327MC$300MC$480MC$508MC$306MC$306MShareholders’ equityEquity
Per share
181M211M259M256M77.2M95.3M109MShares out (diluted)Shares
C$0.07C$0.38C$0.34C$0.31C$1.89C$1.68C$1.47Revenue / shareRev/sh
C$0.11C$-0.05C$-0.53C$-0.51C$-0.18C$-0.48C$-0.42EPS (diluted)EPS
C$-0.07C$-0.17C$-0.18C$-0.12C$-0.54C$-0.01C$-0.01Owner earnings / shareOE/sh
C$-0.38C$-0.68C$-0.47C$-0.16C$-1.10C$-0.01C$-0.01Free cash flow / shareFCF/sh
C$0.31C$0.51C$0.30C$0.05C$0.63C$0.05C$0.04Cap. spending / shareCapex/sh
C$1.02C$1.55C$1.16C$1.87C$6.58C$3.21C$2.82Book value / shareBVPS

Share counts before 2021 are restated ×1.5 for a stock split, so per-share figures sit on one basis.

The diluted share count moved ×1/3.32 into 2022 — shares retired, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
6-yr5-yr
Revenue / share+70.3%/yr+34.5%/yr
Capital spending / share−26.4%/yr−37.4%/yr
Book value / share+21.0%/yr+15.7%/yr

The record, charted

FY2018–2024

Each measure over its full record; the current point and the worst year marked. Share counts on the current split basis.

Share count
95Mpeak FY2020
ROIC
−9%low FY2020
Gross margin
30%low FY2021

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

(C$859K)owner earningsvs.(C$45M)net incomelow FY2020

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2024 the business turned a C$45M loss into (C$859K) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2024FY2022FY2021FY2020FY2019
Reported net income(C$45M)(C$14M)(C$131M)(C$136M)(C$10M)
Depreciation & amortizationnon-cash charge added back+C$4M+C$5M+C$2M+C$2M+C$664K
Working capital & othertiming of cash in and out, other non-cash items+C$45M−C$27M+C$100M+C$90M−C$26M
Cash from operationsC$4M(C$36M)(C$29M)(C$45M)(C$35M)
Maintenance capital expenditurethe spending needed just to hold position and volume−C$5M−C$5M−C$2M−C$2M−C$664K
Owner earnings(C$859K)(C$42M)(C$31M)(C$47M)(C$36M)
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−C$43M−C$9M−C$76M−C$108M
Free cash flow(C$859K)(C$85M)(C$40M)(C$122M)(C$144M)
Owner-earnings marginowner earnings ÷ revenue-1%-28%-39%-54%-44%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position .

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2024 40-F · source on SEC EDGAR →

Will it survive?

  • Does not cover its interest
    Operating income (C$36M) ÷ interest expense C$429K
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net debt against an operating loss
    Cash C$0 − debt C$25K
    What this means

    Netting C$0 of cash and short-term investments against C$25K of debt leaves C$25K owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 85 + DIO 221 − DPO 154 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    5-yr median, range -29%–15%; -9% latest = NOPAT (C$28M) ÷ invested capital C$306M
    Industry peers: median -66%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 5 years (it ran -9% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Consumes cash through the cycle
    6-yr median margin, range -106%–-1%; latest (C$859K) = operating cash C$4M − maintenance capex C$5M
    Industry peers: median -254%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -1% of revenue this year, a -44% median across 6 years.

  • Loss, but cash-generative
    Net income (C$45M) · cash from operations C$4M
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 1.23×
    Expanding
    Capex C$5M ÷ depreciation C$4M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 4 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size
    Revenue ≥ $2B (a dollar floor) · C$160M
    What this means

    Big enough to weather a storm. Graham's floor is a dollar figure — about $2B of revenue as a conservative modern stand-in. This company reports in its home currency and we carry no exchange rate, so we show the figure and leave the size bar for you to apply rather than convert it with a number we don't have.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 4.92×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · C$25K vs C$209M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (6-yr record) · 5 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are C$-0.58/share (latest year C$-0.42), the averaged base the calculator's gate runs on, and book value is C$2.82/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2018–2024

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 1 of 6
    What this means

    Lost money in 5 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 1 of 6 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 44% → −56% (3-yr avg ends)

    In the filing’s words The words explain the slip: the filing names price competition rather than pricing actions of its own — a business that looks to take its price, not set it.

    What this means

    Through the cycle the operating margin slipped — about 44% early to −56% lately, median −30% — competition or costs are biting in.

  • Reinvestment, incremental ROIC −16%
    What this means

    Reinvested capital came back at a negative incremental return over this window — the invested base grew while operating profit did not. The filings show where it went.

  • Worst year 2020 · −167.6% op. margin
    What this means

    Operations went underwater in 2020, understand why before trusting the good years.

  • Share count −3.8%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of fiscal year-end, Sep 30, 2024

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assetsC$262M
  • ReceivablesC$37M
  • InventoryC$67M
  • Other current assetsC$158M
Current liabilitiesC$53M
  • Accounts payableC$47M
  • Other current liabilitiesC$6M
Current ratio4.92×all current assets ÷ what's due · Graham looked for 2×
Quick ratio3.65×stricter: inventory excluded
Cash ratio0.00×strictest: cash alone against what's due
Working capitalC$209Mthe cushion left after near-term bills
Deeper floors
Tangible book valueC$295Mequity stripped of goodwill & intangibles
Net current asset valueC$160MGraham's net-net: current assets less all liabilities
Debt incl. operating leasesC$4MC$4M of it operating leases

From the company's latest filing.

Inverting the record

Invert: instead of why Organigram Global Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2018–2024.

None of the 3 tests turned up a mark; each came back clean. A clean panel says only that these particular ways of being wrong are not written into the record.

Each test came back clean
  • Is it less profitable than it was?
  • Did debt outgrow the business?
  • Did receivables and inventory outpace sales?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Income taxes, Inventory, Acquisitions, Stock compensation as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
RYTMRhythm Pharmaceuticals Inc.$190M90%-238.1%-67%-176%
MRVIMaravai LifeSciences Holdings Inc.$186M53%16.8%-32%21%
STOKStoke Therapeutics Inc.$184M-559.3%-79%-254%
CYRXCryoPort Inc.$176M46%-44.0%-14%-17%
PHATPhathom Pharmaceuticals Inc.$175M86%-502.2%-483%
SNDXSyndax Pharmaceuticals Inc.$172M-3263.2%-64%-2251%
OGIOrganigram Global Inc.C$160M-1%-26.0%-9%-42%
LQDALiquidia Corporation$158M76%-419.6%-163%-266%
Group median65%-328.9%-64%-215%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Enter the US price, in dollars: the NYSE/Nasdaq quote you hold. Organigram Global Inc.'s US listing is the ordinary share itself; figures in this tool are translated at CAD 1 = $0.712 (2026-07-17, reference rate); the dollar quote then reconciles exactly. The record tables elsewhere on this page remain as filed, in CAD.

Organigram Global Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered51%/yr’18→’24

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−1%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "Organigram Global Inc. (OGI), the owner's record," https://ownerscorecard.com/c/OGI, data as of 2026-07-09.

Manual order: ← ODVWZ its page in the Manual OIO →

Industry order: ← OCUL the Pharmaceuticals chapter OGN →